Snowflake Surges 36 After Earnings Beat and 6 Billion AWS Expansion Plan Biotech Stocks Face Headwinds but TopTier Names Show Resilience Global Markets Rally on AI Boom Indian Equities Face Headwinds From Geopolitics and Oil Apples Record High Rally Faces Key Test at June WWDC as AI Strategy Takes Center Stage Zydus Lifesciences Boosts Share Buyback Price to Rs 1260 Reduces Repurchase Size Security Incident Near White House Raises Geopolitical Concerns GTLB Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response TGE Value Creative Solutions Corp BEBE Q3 2016 Earnings Significant EPS Miss Amidst Challenging Quarter GAINI Q1 2026 Earnings EPS Misses Estimates Slightly Note Price Rises MTB Q1 2026 Earnings Earnings Beat Estimates as Net Interest Income Holds Steady CECO Q1 2026 Earnings EPS Surges 1395 Above Estimates Stock Declines Nexxen International Q3 2025 Earnings Strong EPS Surprise Amplifies Confidence in Profitability Ciena Corporation CIEN Consolidates Near 584 After Slight Pullback Niu Technologies NIU Slides 2 to 240 Key Support Levels Under Pressure Jackson Financial JXN Edges Lower as Support Levels Face Test Intellia Therapeutics NTLA Rebounds GeneEditing Stock Shows Promise Near Support Calamos Convertible Opportunities and Income Fund CHI Gains Marginally as Income Seekers Eye Convertible Exposure MidAmerica Apartment Communities Maintains Analyst Support Amid Price Target Adjustments OXSQG Q1 2026 Earnings EPS Misses Estimates as Investment Income Falls Short Xtant Medical Holdings XTNT Tests Key Support Level After Recent Decline CBIZ Inc CBZ Q1 2026 Earnings EPS Beat of 124 Powers Modest Stock Gain SLB Q1 2026 Earnings Marginal EPS Miss Stock Edges Up Amid Mixed Market Signals IMA Q1 2026 Earnings Missed EPS Estimates Amid Continued Pipeline Development UBCP Q4 2022 Earnings Solid EPS Performance Drives Positive Stock Movement FCAP Q1 2026 Earnings EPS of 130 Highlights Cost Discipline Amid Modest Operating Environment BSRR Q1 2026 Earnings EPS Beats Estimates by 144 Shares Edge Higher Verastem Inc Q1 2026 Earnings Narrowerthanexpected loss amid ongoing clinical developments